Proactive approach to improving blood safety
The Mirasol PRT System helps reduce the amount of pathogens from a wide range of viruses, bacteria, and disease-causing parasites.
The system also inactivates residual white blood cells found in blood components, which can help reduce transfusion reactions in patients.
The Mirasol PRT System is the only PRT system proven in a clinical study to reduce the transmission of transfusion-transmitted infections (TTI) of malaria by 87%.
Contact us to find out how the Mirasol PRT system can improve blood safety at your center.
We believe that better blood safety should provide the right balance between effectiveness and ease of use while maintaining the quality of blood components for patients who need them. The Mirasol PRT System is a simple system that has the capability to provide better patient care and reduce the risks associated with life-saving blood donation.
The Mirasol PRT System enables you to meet your business needs by optimizing the balance between cost, efficiency, and the safety of your blood products.
The Mirasol process has fewer steps than other PRT methods, and the device can be used to treat platelets, plasma, and whole blood. This simplicity helps minimize the impact on operations.
The Mirasol PRT System is effective in protecting against a wide range of tested and untested pathogens, including bacteria, parasites, and both enveloped and non-enveloped viruses; it also inactivates white blood cells, adding another layer of safety for patients.
Reduces product discard rates and overall costs for hospitals.
The Mirasol System utilizes a combination of riboflavin (vitamin B2) and UV light to inactivate viruses, bacteria, parasites, and white blood cells, thereby preventing their replication and the spread of disease.
Mirasol is the only pathogen reduction system proven in clinical studies to reduce the risk of transfusion-transmitted infections.
MEDISTYL-PHARMA a.s.
Táborská 57
140 00 Praha 4
Tel: +420 234 091 151, +420 234 091 141
Phone: +420 234 091 156
obchodni@medistylpharma.cz